Sun Pharmaceutical Industries Europe B.V.
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- ESOMEPRAZOL ORION gastro-resistant tablet 20 mg
- ESOMEPRAZOL ORION gastro-resistant tablet 40 mg
- PANTOPRAZOL SUN powder for solution for injection 40 mg
- A10 - Antidiabéticos
- SITAGLIPTIN SUN film-coated tablet 100 mg
- SITAGLIPTIN SUN film-coated tablet 25 mg
- SITAGLIPTIN SUN film-coated tablet 50 mg
- C10 - Agentes modificadores de los lípidos
- ATORVASTATIN ORION film-coated tablet 10 mg
- ATORVASTATIN ORION film-coated tablet 20 mg
- ATORVASTATIN ORION film-coated tablet 40 mg
- ATORVASTATIN ORION film-coated tablet 80 mg
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- FYREMADEL PREFILLED SYRINGE solution for injection 0.25 mg/0.5 ml
- TERLIPRESSIN SUN solution for injection 0.1 mg/1 ml
- TERLIPRESSIN SUN solution for injection 0.85 mg/8.5 ml
- J01 - Antibacterianos para uso sistémico
- MEROPENEM SUN powder for solution for injection 1 000 mg
- MEROPENEM SUN powder for solution for injection 500 mg
- L01 - Antineoplásicos
- AZACITIDINE SUN powder for suspension for injection 100 mg/4 ml
- GEMCITABIN SUN solution for infusion 10 mg/ml
- IRINOTECAN SUN solution for infusion 1.5 mg/ml
- ODOMZO capsule, hard 200 mg
- TEMOZOLOMIDE SUN capsule, hard 100 mg
- TEMOZOLOMIDE SUN capsule, hard 140 mg
- TEMOZOLOMIDE SUN capsule, hard 180 mg
- TEMOZOLOMIDE SUN capsule, hard 20 mg
- TEMOZOLOMIDE SUN capsule, hard 250 mg
- TEMOZOLOMIDE SUN capsule, hard 5 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- ZOLEDRONIC ACID SUN solution for infusion 4 mg/100 ml
- N03 - Antiepilépticos
- LEVETIRACETAM SUN concentrate for solution for infusion 100 mg/ml